Maternal phenylketonuria: A metabolic teratogen

Teratology

Volumn 53, Issue 3, 1996, Pages 176-184

  Levy, Harvey L ^a   Ghavami, Manijeh ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

AMINO ACID BLOOD LEVEL; AMINO ACID TRANSPORT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGENITAL HEART DISEASE; DIET RESTRICTION; DOSE RESPONSE; FACE DYSMORPHIA; FEMALE; FETUS; GENOTYPE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; MENTAL DEFICIENCY; MICROCEPHALY; NEWBORN; NONHUMAN; PHENYLKETONURIA; PLACENTAL TRANSFER; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; TERATOGENESIS;

ABNORMALITIES, MULTIPLE; ALCOHOLISM; ANIMALS; DIAGNOSIS, DIFFERENTIAL; DISEASE MODELS, ANIMAL; FACE; FEMALE; FETAL ALCOHOL SYNDROME; FETAL GROWTH RETARDATION; GENETIC COUNSELING; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; MENTAL RETARDATION; MICE; MICROCEPHALY; PHENYLKETONURIAS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0029977276     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199603)53:3<176::AID-TERA5>3.0.CO;2-2     Document Type: Article

References (59)

1. Allan, J.D., and Brown, J.K. (1968) Maternal phenylketonuria and foetal brain damage: An attempt at prevention by dietary control. In: Some Recent Advances in Inborn Errors of Metabolism. K.S. Holt and V.P. Coffey, eds. E.&S. Livingstone, Edinburgh, pp. 14-36.
2. Bode, V.C., J.D. McDonald, J.-L. Guenet, and D. Simon (1988) hph-1:A mouse mutant with hereditary hyperphenylalaninemia induced by ethylnitrosourea mutagenesis. Genetics, 118:299-305.
3. Bovier-Lapierre, M., C. Saint-Dizier, F. Freycon, M. David, C. Dorche, and M. Jeune (1974) Deux enfants nés de mère phénylcétonurique echec d'un régime pauvre en phénylalanine institué pendant la deuxième grossesse. Pediatrie, 29:51-72.
4. Boyd, C.A.R., and D.L. Yudilevich (1987) Blood-tissue movement of amino acids in various organs: the basolateral membrane and its importance in polarity of transepithelial transport. In: Amino Acid Transport in Animal Cells. D.L. Yudilevich and C.A.R. Boyd, eds. Manchester University Press, Manchester, pp. 120-156.
5. Bromley, B., and B.R. Benacerraf (1995) Difficulties in the prenatal diagnosis of microcephaly. J. Ultrasound Med., 14:303-306.
6. Buist, N.R.M., J. Tuerck, E. Lis, and R. Penn (1984) Effects of untreated maternal phenylketonuria and hyperphenylalaninemia in the fetus. N. Engl. J. Med., 311:52-53.
7. Butcher, R.E. (1970) Learning impairment associated with maternal phenylketonuria in rats. Nature, 226:555-556.
8. Delvalle, J.A., G. Dienel, and O. Greengard (1978) Comparison of α-methylphenylalanine and p-chlorophenylalanine as inducers of chronic hyperphenylalaninaemia in developing rats. Biochem. J., 170:449-459.
9. Denno, K.M., and T.W. Sadler (1990) Phenylalanine and its metabolites induce embryopathies in mouse embryos in culture. Teratology, 42:565-570.
10. Dorland, L., B.T. Poll-The, M. Duran, J.A.M. Smeitink, and R. Berger (1993). Phenylpyruvate, fetal damage, and maternal phenylketonuria syndrome. Lancet, 341:1351-1352.
11. Drogari, E., I. Smith, M. Beasley, and J.K. Lloyd (1987) Timing of strict diet in relation to fetal damage in maternal phenylketonuria. Lancet, 2:927-930.
12. Dyer, C.A., T. Philibotte, H. Levy, and J. Cruz (1995) Mechanisms of hypomyelination and gliosis in a genetic mouse model for phenylketonuria. J. Neurochem., 64 (suppl):S111 (abst.).
13. Fisch, R.O., W.A. Walker, and J.A. Anderson (1966) Prenatal and postnatal developmental consequences of maternal phenylketonuria. Pediatrics, 37:979-986.
14. Foiling, A. (1934) Über Ausscheidung von Phenylbrenztraubensäure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillitäte, Hoppe-Seylers Z. Physiol. Chem., 227:169-176.
15. Ghavami, M., H.L. Levy, and R.W. Erbe (1986) Prevention of fetal damage through dietary control of maternal hyperphenylalaninemia. Clin. Obstet. Gynecol., 29:580-585.
16. Guldberg, P., K.F. Henriksen, and F. Guttler (1993) Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics, 17:141-146.
17. Guthrie, R., and A. Susi (1963) A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics, 32:338-343.
18. Hamers, A.E.P., A.H. Piersma, A. Verhoef, E.J.H.M. Jansen, and P.W.J. Peters (1989) Embryotoxicity of phenylketonuria (PKU)-related metabolites of phenylalanine (phe) is rat whole embryo culture. Teratology, 40:284 (abst.).
19. Held, K.R., and P. Koepp (1980) Maternal Phenylketonuria - Teratological aspects. In: Maternal Phenylketonuria. Problems, Experiences, Recommendations. H. Bickel, ed. Maizena, Frankfurt, pp. 3-9.
20. Hirano, S., Y. Takagi, T. Kanamatsu, and K. Nakai (1985) Effects of hyperphenylalaninemia in the fetal stage on the postnatal development of fetal rat brain. Neurochem Res., 10:1071-1081.
21. Jervis, G.A. (1953) Phenylpyruvic oligophrenia. Deficiency of phenyl-alanine-oxidizing system. Proc. Soc. Exp. Biol. Med., 52:514-515.
22. Jervis, G.A., R.J. Block, D. Boiling, and E. Kanze (1940) Chemical and metabolic studies on phenylalanine. II. The phenylalanine content of the blood and spinal fluid in phenylpyruvic oligophrenia. J. Biol. Chem., 134:105-113.
23. Kerr, G.R., A.S. Chamove, H.F. Harlow, and H.A. Waisman (1968) "Fetal PKU": The effect of maternal hyperphenylalaninemia during pregnancy in the rhesus monkey (Macaca mulatta). Pediatrics, 42:27-36.
24. Kirkman, H.N., and R.E. Hicks (1984) More on untreated maternal hyperphenylalaninemia. N. Engl. J. Med., 311:1125-1126.
25. Koch, R., H.L. Levy, R. Matalon, B. Rouse, W. Hanley, and C. Agen (1993) The North American Collaborative Study of Maternal Phenylketonuria: Status report 1993. Am. J. Dis. Child., 147:1224-1230.
26. Kudo, Y., and C.A.R. Boyd (1990) Transport of amino acids by the human placenta: Predicted effects thereon of maternal hyperphenylalaninaemia. J. Inher. Metab. Dis., 13:617-626.
27. Lenke, R.R., and H.L. Levy (1980) Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N. Engl. J. Med., 303:1202-1208.
28. Lenke, R.R., and H.L. Levy (1982) Maternal phenylketonuria - Results of dietary therapy. Am. J. Obstet. Gynecol., 142:548-553.
29. Levy, H.L. (1994) Reproductive effects of inborn errors of metabolism. In: New Horizons in Neonatal Screening. J.-P. Farriaux and J.-L. Dhondt, eds. Elsevier, Amsterdam, pp. 61-68.
30. Levy, H.L., and A.S. Cornier (1994) Current approaches to genetic metabolic screening in newborns. Curr. Opin. Pediatr., 6:707-711.
31. Levy, H.L., B.S. Goss, D.K. Sullivan, K. Michals-Matalon, J.M. Dobbs, P. Guldberg, and F. Guttler (1994) Maternal mild hyperphenylalaninemia: Results of treated and untreated pregnancies in two sisters. J. Pediatr., 125:467-469.
32. Levy, H.L., R.R. Lenke, and R. Koch (1984) Lack of fetal effect on blood phenylalanine concentration in maternal phenylketonuria. J. Pediatr., 104:245-247.
33. Levy, H.L., D. Lobbregt, R. Koch, and F. de la Cruz (1991) Paternal phenylketonuria. J. Pediatr., 118:741-743.
34. Levy, H.L., D. Lobbregt, L.D. Platt, and B.R. Benacerraf (1996) Fetal ultrasonography in maternal phenylketonuria. Prenat. Diagn. (in press).
35. Levy, H.L., E.W. Naylor, and P. Mamunes (1988) Tissue amino acids and organic acids in the maternal phenylketonuria (MPKU) fetus: implications for the pathogenesis of fetal damage in MPKU. Am. J. Hum. Genet., 43:A12 (abst.).
36. Levy, H.L., and S.E. Waisbren (1983) Effects of untreated maternal phenylketonuria and hyperphenylalaninemia in the fetus. N. Engl. J. Med., 309:1269-1274.
37. Levy, H.L., and S.E. Waisbren (1994a) PKU in adolescents: rationale and psychosocial factors in diet continuation. Acta Paediatr. Suppl., 407:92-97.
38. Levy, H.L., S.E. Waisbren, D. Lobbregt, E. Allred, A. Schuler, F.K. Trefz, S.M. Schweitzer, I.E. Sardharwalla, J.H. Walter, B.E. Barwell, C.M. Berlin, and A. Leviton (1994b) Maternal mild hyperphenylalaninaemia. An international survey of offspring outcome. Lancet, 344:1589-1594.
39. Lipson, A., B. Beuhler, J. Bartley, D. Walsh, J. Yu, M. O'Halloran, and W. Webster (1984) Maternal hyperphenylalaninemia fetal effects. J. Pediatr., 104:216-220.
40. Lipton, M.A., R. Gordon, G. Guroff, and S. Udenfriend (1967) p-Chlorophenylalanine-induced chemical manifestations of phenylketonuria in rats. Science, 156:248-250.
41. Loo, Y.H., A. Rabe, A. Potempska, P. Wang, R. Fersko, and H.M. Wisniewski (1983/84) Dev. Neurosci., 6:227-234.
42. MacCready, R.A. (1974) Admissions of phenylketonuric patients to residential institutions before and after screening programs of the newborn infant. J. Pediatr., 85:383-385.
43. hph-5: A mouse mutant deficient in phenylalanine hydroxylase. Proc. Natl. Acad. Sci. U.S.A., 87:1965-1967.
44. Mitchell, S.C., S.B. Korones, and H.W. Berendes (1971) Congenital heart disease in 56,109 births: Incidence and natural history. Circulation, 43:323-332.
45. Okano, Y., I.Z. Chow, G. Isshiki, A. Inoue, and T. Oura (1986) Effects of phenylalanine loading on protein synthesis in the fetal heart and brain of rat: an experimental approach to maternal phenylketonuria. J. Inher. Metab. Dis., 9:15-24.
46. Pardridge, W.M. (1986) The safety of aspartame. J.A.M.A., 256:2678.
47. Platt, L.D., R. Koch, C. Azen, W.B. Hanley, H.L. Levy, R. Matalon, B. Rouse, F. de la Cruz, and C.A. Walla (1992) Maternal phenylketonuria collaborative study, obstetric aspects and outcome: The first 6 years. Am. J. Obstet. Gynecol., 166:1150-1162.
48. Robson, K.J.H., T. Chandra, R.T.A. MacGillivray, and S.L.C. Woo (1982) Polysome immunoprecipitation of phenylalanine hydroxylase mRNA from rat liver and cloning of its cDNA. Proc. Natl. Acad. Sci. U.S.A., 79:4701-4705.
49. Rohr, F.J., L.B. Doherty, S.E. Waisbren, I.V. Bailey, M.E. Ampola, B. Benacerraf, and H.L. Levy (1987) New England Maternal PKU Project: Prospective study of untreated and treated pregnancies and their outcomes. J. Pediatr., 110:391-398.
50. Rouse, B., L. Lockhart, R. Matalon, C. Azen, R. Koch, W. Hanley, H. Levy, F. de la Cruz, and E. Friedman (1990) Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations. J. Inher. Metab. Dis., 13:289-291.
51. Roux, C., F. Rey, S. Lyonnet, S. Nizard, N. Mulliez, and A. Munnich (1991) An animal model for maternal phenylketonuria. J. Med. Genet., 28:718-719.
52. Sadava, D., and D. Sutcliffe (1988) The effects of maternal hyperphenylalaninemia on learning in mature rats. Life Sci., 43:1119-1123.
53. Schoonheyt, W.E., J.T.R. Clarke, W.B. Hanley, J.M. Johnson, and D.C. Lehotay (1994) Feto-maternal plasma phenylalanine concentration gradient from 19 weeks gestation to term. Clin. Chim. Acta, 225:165-169.
54. Shedlovsky, A., J.D. McDonald, D. Symula, and W.F. Dove (1993) Mouse models of human phenylketonuria. Genetics, 134:1205-1210.
55. Spero, D.A., and M.C. Yu (1983) Effects of maternal hyperphenylalaninemia on fetal brain development: A morphological study. Exp. Neurol., 79:655-665.
56. Spohr, H.-L., J. Willms, and H.-Ch. Steinhausen (1993) Prenatal alcohol exposure and long-term developmental consequences. Lancet, 341:907-910.
57. 14C-leucine into protein in the brain of the fetus. Tohoku J. Exp. Med., 113:173-179.
58. Waisbren, S.E., S. Shiloh, P. St. James, and H.L. Levy (1991) Psychosocial factors is maternal phenylketonuria: Prevention of unplanned pregnancies. Am J Public Health 81:299-304.
59. Waisbren, S.E., B.D. Hamilton, P.J. St. James, S. Shiloh, and H.L. Levy (1995) Psychosocial factors in maternal phenylketonuria: Women's adherence to medical recommendations. Am. J. Public Health, 85:1636-1644.